475 related articles for article (PubMed ID: 7681798)
1. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study.
Rindi G; Luinetti O; Cornaggia M; Capella C; Solcia E
Gastroenterology; 1993 Apr; 104(4):994-1006. PubMed ID: 7681798
[TBL] [Abstract][Full Text] [Related]
2. Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases.
Bordi C; Yu JY; Baggi MT; Davoli C; Pilato FP; Baruzzi G; Gardini G; Zamboni G; Franzin G; Papotti M
Cancer; 1991 Feb; 67(3):663-72. PubMed ID: 1702355
[TBL] [Abstract][Full Text] [Related]
3. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association.
Solcia E; Capella C; Fiocca R; Rindi G; Rosai J
Am J Surg Pathol; 1990 Jun; 14(6):503-13. PubMed ID: 1970928
[TBL] [Abstract][Full Text] [Related]
4. Gastric carcinoids of argyrophil ECL cells.
Capella C; Polak JM; Timson CM; Frigerio B; Solcia E
Ultrastruct Pathol; 1980; 1(3):411-8. PubMed ID: 7233595
[TBL] [Abstract][Full Text] [Related]
5. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior.
Rindi G; Bordi C; Rappel S; La Rosa S; Stolte M; Solcia E
World J Surg; 1996 Feb; 20(2):168-72. PubMed ID: 8661813
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic aspects of gastric neuroendocrine tumors.
Rindi G
Am J Surg Pathol; 1995; 19 Suppl 1():S20-9. PubMed ID: 7762736
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of ECL cell tumors in humans.
Bordi C; D'Adda T; Azzoni C; Ferraro G
Yale J Biol Med; 1998; 71(3-4):273-84. PubMed ID: 10461358
[TBL] [Abstract][Full Text] [Related]
8. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
Gilligan CJ; Lawton GP; Tang LH; West AB; Modlin IM
Am J Gastroenterol; 1995 Mar; 90(3):338-52. PubMed ID: 7872269
[TBL] [Abstract][Full Text] [Related]
9. Gastric carcinoid tumors, endocrine cell hyperplasia, and associated intestinal metaplasia. Histologic, histochemical, and immunohistochemical findings.
Mendelsohn G; de la Monte S; Dunn JL; Yardley JH
Cancer; 1987 Sep; 60(5):1022-31. PubMed ID: 2440553
[TBL] [Abstract][Full Text] [Related]
10. The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndromes.
Bordi C; Corleto VD; Azzoni C; Pizzi S; Ferraro G; Gibril F; Delle Fave G; Jensen RT
J Clin Endocrinol Metab; 2001 May; 86(5):2236-42. PubMed ID: 11344233
[TBL] [Abstract][Full Text] [Related]
11. Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas.
Bashir S; Gibril F; Ojeaburu JV; Asgharian B; Entsuah LK; Ferraro G; Crafa P; Bordi C; Jensen RT
Aliment Pharmacol Ther; 2002 Jul; 16(7):1367-82. PubMed ID: 12144588
[TBL] [Abstract][Full Text] [Related]
12. Gastric carcinoid associated with the syndrome of hypergastrinemic atrophic gastritis. A prospective analysis of 11 cases.
Borch K; Renvall H; Kullman E; Wilander E
Am J Surg Pathol; 1987 Jun; 11(6):435-44. PubMed ID: 3592060
[TBL] [Abstract][Full Text] [Related]
13. Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids.
Azzoni C; Doglioni C; Viale G; Delle Fave G; De Boni M; Caruana P; Ferraro G; Bordi C
Am J Surg Pathol; 1996 Apr; 20(4):433-41. PubMed ID: 8604810
[TBL] [Abstract][Full Text] [Related]
14. Carcinoids of the duodenum. A histologic and immunohistochemical study of 65 tumors.
Burke AP; Federspiel BH; Sobin LH; Shekitka KM; Helwig EB
Am J Surg Pathol; 1989 Oct; 13(10):828-37. PubMed ID: 2476943
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine differentiation in 32 cases of so-called sclerosing hemangioma of the lung: identified by immunohistochemical and ultrastructural study.
Xu HM; Li WH; Hou N; Zhang SG; Li HF; Wang SQ; Yu ZY; Li ZJ; Zeng MY; Zhu GM
Am J Surg Pathol; 1997 Sep; 21(9):1013-22. PubMed ID: 9298877
[TBL] [Abstract][Full Text] [Related]
16. [Primary gastric endocrine tumors].
Liu SM; Liu XY; Zou SM; Wei GL; Sun YT
Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):38-42. PubMed ID: 12760802
[TBL] [Abstract][Full Text] [Related]
17. Hypergastrinemia and gastric enterochromaffin-like cells.
Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
[TBL] [Abstract][Full Text] [Related]
18. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids.
Debelenko LV; Emmert-Buck MR; Zhuang Z; Epshteyn E; Moskaluk CA; Jensen RT; Liotta LA; Lubensky IA
Gastroenterology; 1997 Sep; 113(3):773-81. PubMed ID: 9287968
[TBL] [Abstract][Full Text] [Related]
19. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.
Richards ML; Gauger P; Thompson NW; Giordano TJ
World J Surg; 2004 Jul; 28(7):652-8. PubMed ID: 15383867
[TBL] [Abstract][Full Text] [Related]
20. Management of carcinoid tumors of the stomach, duodenum, and pancreas.
Akerström G
World J Surg; 1996 Feb; 20(2):173-82. PubMed ID: 8661814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
